Publications

Title

Author

Year

Epidemiology and transmission dynamics of Streptococcus pneumoniae in low and lower-middle income settings: implications for vaccination strategies.

Le Polain de Waroux, O;

2017

(2017). 10.17037/PUBS.04503937.

The Typhoid Vaccine Acceleration Consortium (TyVAC): Vaccine effectiveness study designs: Accelerating the introduction of typhoid conjugate vaccines and reducing the global burden of enteric fever. Report from a meeting held on 26-27 October 2016, Oxf...

Meiring, JE; Gibani, M; Basnyat, B; Bentsi-Enchill, AD; Clemens, J; Darton, TC; Date, K; Dougan, G; Garrett, D; Gessner, BD; Gordon, MA; Heyderman, RS; Hombach, J; Kotloff, KL; Levine, MM; Luby, SP; Mohan, VK; Marfin, AA; MULHOLLAND, K; Neuzil, K; Pitzer, VE; Pollard, AJ; Qadri, F; Salisbury, D; Zaidi, A; ... Ty, VC M G.

2017

Vaccine, (2017).35 38 10.1016/j.vaccine.2017.08.001.

Controversial Ebola vaccine trials in Ghana: a thematic analysis of critiques and rebuttals in digital news.

Kummervold, PE; SCHULZ, WS; SMOUT, E; Fernandez-Luque, L; LARSON, HJ;

2017

BMC public health, (2017).17 1 10.1186/s12889-017-4618-8.

Carriage prevalence and serotype distribution of Streptococcus pneumoniae prior to 10-valent pneumococcal vaccine introduction: A population-based cross-sectional study in South Western Uganda, 2014.

Nackers, F; Cohuet, S; LE POLAIN DE WAROUX, O; Langendorf, C; Nyehangane, D; Ndazima, D; Nanjebe, D; Karani, A; Tumwesigye, E; Mwanga-Amumpaire, J; SCOTT, JA G; Grais, RF;

2017

Vaccine, (2017).35 39 10.1016/j.vaccine.2017.07.081.

Burden of paediatric respiratory syncytial virus disease and potential effect of different immunisation strategies: a modelling and cost-effectiveness analysis for England.

Cromer, D; VAN HOEK, AJ; Newall, AT; Pollard, AJ; JIT, M;

2017

The lancet Public health, (2017).2 8 10.1016/S2468-2667(17)30103-2.

The benefit of the doubt or doubts over benefits? A systematic literature review of perceived risks of vaccines in European populations.

KARAFILLAKIS, E; LARSON, HJ; ADVANCE consortium,;

2017

Vaccine, (2017).35 37 10.1016/j.vaccine.2017.07.061.

The public health value of vaccines beyond efficacy: methods, measures and outcomes.

WILDER-SMITH, A; Longini, I; Zuber, PL; Bärnighausen, T; EDMUNDS, WJ; Dean, N; Spicher, VM; Benissa, MR; Gessner, BD;

2017

BMC medicine, (2017).15 1 10.1186/s12916-017-0911-8.

Sustained reduction in vaccine-type invasive pneumococcal disease despite waning effects of a catch-up campaign in Kilifi, Kenya: A mathematical model based on pre-vaccination data.

OJAL, J; FLASCHE, S; Hammitt, LL; Akech, D; Kiti, MC; Kamau, T; ADETIFA, I; Nurhonen, M; SCOTT, JA G; Auranen, K;

2017

Vaccine, (2017).35 35 Pt 10.1016/j.vaccine.2017.07.019.

Who is Spreading Rumours about Vaccines?.

Kostkova, P; Mano, V; LARSON, HJ; Schulz, WS;

2017

Proceedings of the 2017 International Conference on Digital Health (2017). 10.1145/3079452.3079505.

Observational study to estimate the changes in the effectiveness of bacillus Calmette-Guérin (BCG) vaccination with time since vaccination for preventing tuberculosis in the UK.

MANGTANI, P; NGUIPDOP-DJOMO, P; KEOGH, RH; Trinder, L; SMITH, PG; FINE, PE; Sterne, J; Abubakar, I; VYNNYCKY, E; Watson, J; Elliman, D; Lipman, M; RODRIGUES, LC;

2017

HEALTH TECHNOLOGY ASSESSMENT, (2017).21 39 10.3310/hta21390.